BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36414349)

  • 1. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
    Betancur V; Net J; Chapman J; Yepes M
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
    Dalugama C; Gawarammana IB
    J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report.
    Racette SD; Alexiev BA; Angarone MP; Bhasin A; Lima K; Jennings LJ; Balasubramanian S; Matsuoka AJ
    BMC Infect Dis; 2021 Aug; 21(1):740. PubMed ID: 34344305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto Disease and Prognostic Implications.
    Salamat S; Chan J; Jolly K; Powell G; Harrison K; Ahanger S; Hari C
    Head Neck Pathol; 2020 Mar; 14(1):272-275. PubMed ID: 30888636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
    Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
    [No Abstract]   [Full Text] [Related]  

  • 8. A familial case of Kikuchi-Fujimoto disease in dizygotic twins.
    Quadir A; Peacock K; Hsu P; Singh-Grewal D; Alexander S
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):62. PubMed ID: 32778173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) of axillary lymph nodes.
    Nagaraju S; Vaishnav S; Burke LH; Norman EM
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25564582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis.
    Watanabe T; Hashidate H; Hirayama Y; Iinuma Y
    Eur J Pediatr; 2012 Sep; 171(9):1409-11. PubMed ID: 22476507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kikuchi-Fujimoto lymphadenitis in a 29-year-old female patient].
    Magutová J
    Internist (Berl); 2016 Jan; 57(1):90-3. PubMed ID: 26684186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
    Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
    Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kikuchi-Fujimoto disease: a rare cause of cervical lymphadenopathy and fever.
    Wong YK; Khan M
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30097545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Recurrent Cervical Lymphadenopathy Due to Kikuchi-Fujimoto Disease.
    Alsolami A; Altirkistani R; Tayeb S; Albeshri T; Estaitieh O; Rabie N; Fadag R; Samannodi M
    Am J Case Rep; 2021 Feb; 22():e928760. PubMed ID: 33583938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kikuchi-Fujimoto Disease: A Case of SARS-CoV-2 Infection Triggering the Rare Disease.
    Lencastre Monteiro R; Cabaço S; Soares L; Inácio H; Nazário Leão R
    Cureus; 2023 Mar; 15(3):e35858. PubMed ID: 37033518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful management of Kikuchi-Fujimoto disease caused by SARS-CoV-2].
    Iszlai Z; Török L; Tóth E; Karosi T
    Orv Hetil; 2022 Jul; 163(27):1061-1065. PubMed ID: 35895470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi-Fujimoto disease triggered by Salmonella enteritidis in a child with concurrent auto-immune thyroiditis and papilloedema.
    Altinel Açoğlu E; Sari E; Şahin G; Oğuz MM; Akçaboy M; Zorlu P; Senel S
    Paediatr Int Child Health; 2018 Nov; 38(4):298-301. PubMed ID: 29307273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kikuchi-Fujimoto Disease Associated With Mycoplasma Pneumoniae Infection.
    Yu RB; Chen YJ; Chang CH; Chen YL; Chen JW
    Ear Nose Throat J; 2024 Apr; 103(4):NP223-NP225. PubMed ID: 34605286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kikuchi-Fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report.
    Cho E; Baek HJ; Bae K; Jeon KN; Moon JI; Park SE; Lee HS; An HJ
    Curr Med Imaging; 2023 Jun; ():. PubMed ID: 37340742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kikuchi-Fujimoto disease associated with a flare-up of a leukocytoclastic vasculitis: A rare case report and review of literature.
    Sandakly N; El Koubayati G; Sarkis J; Naderi S; Sebaaly D; Haddad F
    Medicine (Baltimore); 2024 Mar; 103(13):e37626. PubMed ID: 38552071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.